Aquestive Therapeutics shares are trading higher after analysts at Wedbush and Lake Street raised their price targets on the stock.
Portfolio Pulse from Benzinga Newsdesk
Aquestive Therapeutics' stock price increased following price target upgrades from analysts at Wedbush and Lake Street.
March 07, 2024 | 8:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aquestive Therapeutics' stock price is likely to experience a short-term increase following the upgraded price targets from Wedbush and Lake Street.
Analyst ratings and price target adjustments are significant indicators of a stock's potential movement. The upgrades from respected firms like Wedbush and Lake Street suggest a positive outlook on AQST's value, likely leading to increased investor interest and a short-term price rise.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90